Tevogen Bio Holdings INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
Tevogen Inc. has announced its 2026 Annual Meeting of Stockholders, scheduled for August 24, 2026, to elect directors, ratify auditors, and approve amendments to its incentive plan and charter.
NASDAQ
Tevogen Bio Holdings Inc. calls a special meeting to vote on a reverse stock split to maintain Nasdaq listing and a significant increase in its equity incentive plan shares.
NASDAQ
Tevogen Bio Holdings Inc. has filed a definitive proxy statement with the SEC.
NASDAQ
Tevogen Bio Holdings Inc. will hold its 2025 Annual Meeting of Stockholders virtually on June 23, 2025, to elect directors and ratify the appointment of KPMG LLP as the company's independent registered public accounting firm.
NASDAQ
Tevogen Bio will hold its 2025 annual meeting of stockholders via live webcast on June 23, 2025, to vote on director re-election and ratification of the company's accounting firm.